Sara Blum Sherman

Investor Relations Contact at EXSCIENTIA PLC

Health Technology

Technology Services

Profile

Sara Blum Sherman is currently working as Vice President-Investor Relations at Exscientia AI Ltd. and Exscientia Plc.
She previously worked as Senior Director-Investor Relations & Strategy at DBV Technologies SA from 2016 to 2020 and as Head-Investor Relations at UroGen Pharma Ltd.

Sara Blum Sherman active positions

Companies	Position	Start
EXSCIENTIA PLC	Investor Relations Contact	2021-07-31
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Investor Relations Contact	-

All active positions of Sara Blum Sherman

Former positions of Sara Blum Sherman

Companies	Position	End
UROGEN PHARMA LTD.	Investor Relations Contact	2021-07-31
DBV TECHNOLOGIES	Public Communications Contact	2020-08-31

See the detail of Sara Blum Sherman's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sara Blum Sherman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
DBV Technologies SA DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy	Health Technology
UroGen Pharma Ltd. UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies	Health Technology
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Health Technology
Exscientia Plc Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services	Technology Services